CLSI A One Health Perspective on Susceptibility …

1 CLSI –A One Health Perspective on Susceptibility Testing Dr. Jeffrey L. Watts, PhD, RM (NRCM), M (ASCP) Director, External Innovation –Anti-Infectives Zoetis, Inc

  Health, Perspective, Testing, One health perspective on susceptibility, Susceptibility, One health perspective on susceptibility testing

CT - jscm.org

ct 6 ˘ˇ ˆ˙˝ ˘ ˛˚ ˜ ˘˚ ! "#$ %& ’( ) *˘ ˇ+,)- .ˆ’(˙/ ˇ˝ ˛ ˚˜ !" 01#234$5

Moraxella osloensis 1 - jscm.org

4 dna 16s rrna ˘ ˇˆ8ua (5 -agagtttgatcmtggctcag-3 ), 1485b (5 -taccgttaccttgttacgac-3 ) ˙ ˝˛˚˜ pcr ˘ pcr

  Moraxella osloensis, Moraxella, Osloensis

TRC TRCRapid M. TB - jscm.org

pcr n- -a- ˘(nalc) ˇ ˆ ˙84 ˝˛ 67 ˚˛˜ 8 ˚˛!"#$ % 3 ˚˛&’3 ˚˛ 2 ˚˛( )*1 ˚˝ +nalc ˇ ˆ˙,- .˘/01234 (pbs) ˝1,000 ml˛pcr ˙ 5 100 ml˛

  Nalc, Trc trcrapid m, Trcrapid

バンコマイシン耐性腸球菌 - jscm.org

10 日本臨床微生物学雑誌 Vol.24 No.3 2014. Ⓒ日本臨床微生物学会2014 [総 説] バンコマイシン耐性腸球菌 富田治芳 1）2）・野村隆浩・久留島潤・谷本弘一2） 1）群馬大学大学院医学系研究科細菌学分野 2）群馬大学大学院医学系研究科附属薬剤耐性菌実験施設 （平成26年7月31日受付）

  Smcj

coagulase-negative staphylococci

7) 2003. 4: 153 155. 8) Kirchho#,L.V., J. N. Sheagren. 1985. Epidemi-ology and clinical significance of blood cul-tures positive for coagulase-negative staphylo-

  Negative, Coagulase negative staphylococci, Coagulase, Staphylococci

Loop-mediated isothermal amplification（LAMP） …

LAMP法によるレジオネラ属菌の検出 6×106 CFU/mlおよび約6×108 CFU/mlに希釈し た。これらは95℃で5分間の熱処理後，氷冷して， 12,000 rpm，4℃，10分間の遠心分離を行 …

  Lamp

ƒ⁄‹ˇˆ˙ . 2007 53 - jscm.org

Acinetobacter ursingii Nemec et al. 2001 51: 1898 2 Actinobacillus capsula-tus Arseculeratne 1962 30: 241 1980 Class 2 2(t) Actinobacillus delphini-

  2007, Smcj, 2007 53 jscm

Fusobacterium necrophorum - jscm.org

ACase of Retropharyngeal Lymph Node Abscess Which Fusobacterium necrophorum Was Isolated from Blood Culture Keiko Kaiho,1) Naruhiko Ishiwada,1) Haruka Hishiki,1) Masaharu Watanabe,2) Yoichi Kohno1)

  Smcj, Fusobacterium necrophorum, Fusobacterium, Necrophorum

広域β-ラクタム薬耐性に関与するβ-ラクタマーゼの …

荒川宜親 14 日本臨床微生物学雑誌 Vol.13 No.3 2003. 152 までには至っていなかった。しかし，1990年には， プラスミド依存性にCAZに耐性を獲得したKlebsiella

Guidelines for Diagnosis, Treatment, and Prevention of ...

478 nature publishing group The American Journal of GASTROENTEROLOGY VOLUME 108 | APRIL 2013 www.amjgastro.com PRACTICE GUIDELINES INTRODUCTION Clostridium diffi cile inf ection (CDI) is a leading cause of hospital-associated gastrointestinal illness and places a high burden on our

  Guidelines, Treatment, Clostridium, Diagnosis, Guidelines for diagnosis, Lice, Clostridium diffi cile, Diffi

Laboratory Testing for Clostridium difficile - FADONA

1 Clostridium difficile Infection (CDI) Prevention Collaborative Laboratory Testing Information Introduction The purpose of this document is to provide an overview of the Clostridium difficile infection (CDI) lab tests available to diagnose CDI in order to assist healthcare facilities with optimizing

  Laboratory, Testing, Laboratory testing, Clostridium difficile, Clostridium, Difficile

Clostridium difficile - Glutamate Dehydrogenase (GDH)

Clostridium difficile - Glutamate Dehydrogenase (GDH) Providing a range of NHS services in Gateshead, South Tyneside and Sunderland. Infection Prevention Control

  Clostridium, Difficile, Dehydrogenase, Glutamate, Clostridium difficile glutamate dehydrogenase

Clinical Practice Guidelines for Clostridium difficile ...

432 infection control and hospital epidemiology may 2010, vol. 31, no. 5 6. Testing of stool from asymptomatic patients is not clinically useful, including use as a test of cure.

  Guidelines, Practices, Clostridium, Clinical, Clinical practice guidelines for clostridium